None listed
Conditions
Brief summary
Primary purpose of the study: To find out whether educational videos targeting intestinal worm prevention at school widens the students' knowledge and changes their behaviour, resulting in fewer STH infections in Hunan Province, China. The following hypothesis will be tested: -The intervention group’s knowledge on intestinal worms transmission, symptoms, treatment and their disease awareness/notion will increase. -The intervention group’s infection risk behaviour will change more significantly such that the risk of intestinal worm re-infection decreases. -Less intestinal worm re-infections will occur in the intervention group due to the video. With the help of questionnaires, behaviour observations and parasitological stool examinations, the effect of the video will be tested in 30 intervention schools (video shown) and compared with the outcome in 30 control schools (video not shown).
Interventions
Health education DVD: narrative 10min Cartoon video. Content: story about a boy who gets infected with STH because of unhygienic bahaviour. Key messages: 1) symptoms of the disease. 2) where and how can children get infected. 3) how can disease be prevented. DVD will be shown twice in October 2010 and twice in March 2011 at each of the 30 intervention schools. The Albendazole treatment will take place twice, once after the baseline parasitological survey in October 2010 and once after the folow-
Health education DVD: narrative 10min Cartoon video. Content: story about a boy who gets infected with STH because of unhygienic bahaviour. Key messages: 1) symptoms of the disease. 2) where and how can children get infected. 3) how can disease be prevented. DVD will be shown twice in October 2010 and twice in March 2011 at each of the 30 intervention schools. The Albendazole treatment will take place twice, once after the baseline parasitological survey in October 2010 and once after the folow-up parasitological survey in June 2011. Albendazole treatment of positives: a single oral dose of Albendazole (400mg) according to World Health Organization (WHO) guidelines.
Sponsors
Donald P McManus
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
9 Years to 11 Years
Healthy volunteers
Yes
Inclusion criteria
pupil of school pupil at school for duration of study resident of selected village informed consent obtained age 9-11
Exclusion criteria
no informed consent outside of specified age range pupil will not be present for duration of study
Outcome results
None listed